BIOZORB 3D BIOABSORBABLE MARKER F020-LOG590537

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-01-22 for BIOZORB 3D BIOABSORBABLE MARKER F020-LOG590537 manufactured by Focal Therapeutics, A Hologic Company.

Event Text Entries

[176300347] A (b)(6) y/o female had significant chronic pain and swelling in her left breast after her lumpectomy and sentinel node biopsy for breast cancer in (b)(6) 2018. Patient felt that she had allergic reaction to the biosorb device that was placed at the time of surgery, and had skin testing with shaved parts of pla. The skin testing was clearly positive. She requested to have the biosorb remove. During surgery, the biosorb was identify intact without any signs of incorporation by the body. Fda safety report id # (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5092435
MDR Report Key9622123
Date Received2020-01-22
Date of Report2020-01-20
Date of Event2020-01-14
Date Added to Maude2020-01-23
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOZORB 3D BIOABSORBABLE MARKER
Generic NameMARKER RADIOGRAPHIC, IMPLANTABLE
Product CodeNEU
Date Received2020-01-22
Model NumberF020-LOG590537
Lot NumberA1-180606
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerFOCAL THERAPEUTICS, A HOLOGIC COMPANY
Manufacturer AddressSUNNYVALE CA 94085 US 94085


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.